This set of malaria awareness posters, created by the National Institute for Communicable Diseases (NICD), provides the general public in South Africa with clear visual messages about malaria prevention, symptoms and the importance of early treatment. Designed for community outreach, the posters enc...ourage key protective behaviours such as using bed nets, seeking prompt medical attention, and recognising the signs of infection.
Accessed on 20/06/2025.
more
No publication year indicated.
Original file: 21 MB
La publicación está dirigida al personal de salud, con el fin de fortalecer capacidades de los miembros de la comunidad educativa para la adopción de prácticas saludables que favorezcan la salud respiratoria y la prevención de enfermedades respiratorias. La salud respiratoria tiene un impacto p...ositivo en el desempeño del escolar, ya que permite el buen funcionamiento de otros órganos del cuerpo, por tanto, contribuye a la salud integral del niño y del adolescente. Cuanto más saludable estén las personas, estarán en mejores condiciones para crecer, aprender y desarrollar habilidades y destrezas.
more
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...serious adverse events (SAEs).
more
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...ing access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
more